Sunzen Biotech Bhd Cash Flow Reinvestment Rate
Sunzen Biotech Bhd cash flow reinvestment rate. Sunzen Biotech Bhd (0148) has a Cash Flow Reinvestment Rate of 0.04x as of September 2023, reinvesting RM145.00K (capex RM95.00K plus investments RM50.00K) from operating cash flow of RM3.58 Million. Explore 0148 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Sunzen Biotech Bhd (2016–2023)
Cash flow reinvestment rate of Sunzen Biotech Bhd from 2016 to 2023. Historical reinvestment intensity for Sunzen Biotech Bhd across 4 annual periods. Explore 0148 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Sunzen Biotech Bhd Cash Flow Reinvestment Rate by Year (2016–2023)
Sunzen Biotech Bhd cash flow reinvestment rate by year from 2016 to 2023. Year-by-year capital reinvestment analysis for Sunzen Biotech Bhd. For the full cash flow conversion analysis, see Sunzen Biotech Bhd cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (MYR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 2.96x | RM2.43 Million | RM819.39K | RM1.01 Million | ▲ +1495.8% |
| 2020 | 0.19x | RM1.34 Million | RM7.20 Million | RM1.16 Million | ▼ -87.5% |
| 2017 | 1.49x | RM5.98 Million | RM4.02 Million | RM3.42 Million | ▼ -95.7% |
| 2016 | 34.76x | RM8.90 Million | RM256.13K | RM6.64 Million | — |